Shuttle Pharmaceuticals Holdings Free Cash Flow (FCF) History (SHPH)

Shuttle Pharmaceuticals Holdings reported −$12.5M in free cash flow for fiscal 2025, a decrease of $6.9M from the previous fiscal year.

View full Shuttle Pharmaceuticals Holdings company overview

Shuttle Pharmaceuticals Holdings free cash flow by year

Shuttle Pharmaceuticals Holdings annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$12.5M−$6.9M
20232023-12-31−$5.6M

Shuttle Pharmaceuticals Holdings free cash flow growth trends

Shuttle Pharmaceuticals Holdings's latest reported quarter, Q1 2026, generated −$2.5M in free cash flow.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Shuttle Pharmaceuticals Holdings filings at SEC.gov ↗